News

Deal Announcements

Aragon Pharma Nets Venture Capital Funding

Thursday, September 27, 2012 5:54:00 AM PDT | VentureDeal
   San Diego, California  --  Aragon Pharmaceuticals has garnered $50 million in new venture capital financing, according to an SEC regulatory filing.

Aragon is developing anti-endocrine therapies targeting the biology of hormonally-driven cancers.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1